Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,133 JPY | -1.03% | +2.76% | +1.97% |
06-25 | US CDC alerts healthcare providers of increase in dengue cases | RE |
06-25 | Takeda's Cancer Drug Gets European Commission Approval | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.97% | 40.23B | |
+55.19% | 801B | |
+47.26% | 631B | |
-6.09% | 359B | |
+21.92% | 337B | |
+18.40% | 245B | |
+3.64% | 231B | |
+12.98% | 219B | |
+10.86% | 171B | |
-2.78% | 161B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Transcript : Takeda Pharmaceutical Company Limited Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-12-2022 02